SBI Securities’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.1K Sell
14,603
-1,190
-8% -$3.02K ﹤0.01% 1237
2026
Q1
$31K Buy
15,793
+809
+5% +$1.9K ﹤0.01% 1289
2025
Q4
$40.6K Sell
14,984
-5,098
-25% -$16.7K ﹤0.01% 1162
2025
Q3
$84.9K Sell
20,082
-1,460
-7% -$6.42K ﹤0.01% 903
2025
Q2
$107K Sell
21,542
-1,082
-5% -$4.7K ﹤0.01% 792
2025
Q1
$99.8K Buy
22,624
+2,748
+14% +$12.9K ﹤0.01% 750
2024
Q4
$92.4K Buy
+19,876
New +$109K ﹤0.01% 784

Other funds holding GDRX

SBI Securities's GDRX Position: Q2 2026 in Review

SBI Securities reduced its GoodRx Holdings (GDRX) stake by 7.5% in Q2 2026, selling an estimated $3.02K and leaving 14,603 shares worth $42.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.

SBI Securities first reported a position in GDRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $107K in Q2 2025. 163 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • SBI Securities held 14,603 shares of GoodRx Holdings worth $42.1K as of Q2 2026.
  • SBI Securities sold 1,190 GoodRx Holdings shares in Q2 2026, an estimated $3.02K.
  • GoodRx Holdings made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1237 holding.
  • SBI Securities first reported a position in GoodRx Holdings in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's GoodRx Holdings position peaked at $107K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.